Streetbeat News

Products Services

TVGN

Tevogen Bio (NASDAQ:TVGN) plans to unveil its $1B+ revenue potential starting the week of October 14, 2024. The company is focused on developing T cell therapeutics for infectious diseases and cancers, with a unique and cost-efficient drug development model.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 2:11 pm

QCOM

Deep-pocketed investors are showing a bullish sentiment towards Qualcomm (NASDAQ:QCOM) as revealed by Benzinga's options scanner. The options activity is unusual, with a significant number of calls and puts indicating a price range of $155 to $180. Qualcomm's stock is currently trading at $171.88, up by 1.12%, and may be approaching overbought territory.

Portfolio Pulse from Benzinga Insights

October 14, 2024 | 2:00 pm

BTCUSD

DOGEUSD

ETHUSD

SPY

TSLA

Tesla's aggressive price cuts have led to a 25% drop in used EV prices, impacting dealers. Meanwhile, Bitcoin, Ethereum, and Dogecoin have fallen due to fears of a US government sell-off, though analysts predict a potential upside for Bitcoin. Nasdaq and S&P 500 futures are rising ahead of the Q3 earnings season, with strong earnings from JPMorgan and Wells Fargo driving record highs for the Dow and S&P 500.

Portfolio Pulse from Akanksha Bakshi

October 14, 2024 | 1:57 pm

SYK

TMCI

Treace Medical Concepts has filed a lawsuit against Stryker Corporation and its subsidiary Wright Medical Technology for patent infringement and unfair competition related to its Lapiplasty Bunion Technology.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:52 pm

FBTC

IBIT

Bitcoin and Ethereum ETFs saw a significant inflow of $407 million, driven by political shifts favoring Republicans, perceived as crypto-friendly. The iShares Bitcoin Trust and Fidelity Wise Origin Bitcoin Fund were major beneficiaries. Bitcoin's price surged to $64,875.

Portfolio Pulse from Ivan Crnogatić

October 14, 2024 | 1:50 pm

IGV

NOW

XDAT

ServiceNow plans to invest $1.5 billion in the UK over the next five years, expanding its workforce and enhancing data centers with Nvidia GPUs. This move aims to leverage AI and provide reskilling opportunities for UK workers. ServiceNow shares are trading higher following the announcement.

Portfolio Pulse from Lekha Gupta

October 14, 2024 | 1:46 pm

LLY

The FDA is reconsidering its ban on compounding pharmacies supplying cheaper versions of Eli Lilly's weight loss and diabetes drugs. This follows a complaint from compounding groups and a shortage of Eli Lilly's tirzepatide injection, branded as Mounjaro and Zepbound.

Portfolio Pulse from Vandana Singh

October 14, 2024 | 1:43 pm

LBPH

H. Lundbeck A/S has agreed to acquire Longboard Pharmaceuticals, Inc for $60.00 per share, valuing the transaction at approximately $2.6 billion. The acquisition is expected to close in Q4 2024. Longboard's lead asset, bexicaserin, is under development for neurological diseases and has received FDA designations. The acquisition will diversify Lundbeck's revenue growth, with expected global peak sales of $1.5 billion to $2 billion.

Portfolio Pulse from Vandana Singh

October 14, 2024 | 1:34 pm

EPOW

Sunrise New Energy Co., Ltd. (NASDAQ:EPOW) has secured $1.04 million in funding for its innovative silicon-carbon anode project, approved by the Guizhou Provincial Department of Science and Technology. The project promises significant advancements in lithium-ion battery technology.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:29 pm

FXI

VGK

The EU has received price undertaking offers from the Chinese Chamber of Commerce and separate EV exporters regarding electric vehicles. However, reaching an agreement by the end of October seems challenging. A single minimum price as an alternative to tariffs is not feasible.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:28 pm